Embecta Corp. (EMBC)
NASDAQ: EMBC · Real-Time Price · USD
14.10
+0.49 (3.60%)
Nov 21, 2024, 1:32 PM EST - Market open
Embecta Market Cap
Embecta has a market cap or net worth of $813.60 million as of November 21, 2024. Its market cap has decreased by -8.58% in one year.
Market Cap
813.60M
Enterprise Value
2.16B
1-Year Change
-8.58%
Ranking
Category
Stock Price
$14.10
Market Cap Chart
Since March 22, 2022, Embecta's market cap has decreased from $2.68B to $813.60M, a decrease of -69.60%. That is a compound annual growth rate of -35.99%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 20, 2024 | 785.32M | -27.94% |
| Dec 29, 2023 | 1.09B | -24.67% |
| Dec 30, 2022 | 1.45B | -45.94% |
| Mar 22, 2022 | 2.68B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Erasca | 788.81M |
| Autolus Therapeutics | 785.06M |
| Evolus | 784.55M |
| Avid Bioservices | 779.62M |
| Pliant Therapeutics | 778.32M |
| Cronos Group | 774.25M |
| Pacira BioSciences | 772.48M |
| Avanos Medical | 768.27M |